| Financial Year |
March 31 2023 |
| Monetary Funds |
2,725,091,496.47 |
| Held-for-trading Financial Assets |
50,470,180.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
178,360,707.57 |
| Advances to Suppliers |
31,778,106.73 |
| Other Receivables |
16,128,651.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,004,467.29 |
| Inventories |
13,877,642.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,903,757.39 |
| Total Current Assets |
3,029,610,542.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,442,436,692.09 |
| Investment Properties |
61,823,313.06 |
| Fixed Assetes |
12,901,638.89 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,328,861.04 |
| R&D expenses |
-- |
| Goodwill |
246,035,314.16 |
| Long-Term Deferred and Prepaid Expenses |
716,391.88 |
| Deferred Income Tax Assets |
42,749,511.29 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,118,761,022.62 |
| Total Assets |
5,148,371,565.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
114,918,279.29 |
| Accounts Received In Advance |
808,454.25 |
| Employee Compensation Payable |
104,886,377.35 |
| Taxes Payable |
26,696,554.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,963,371.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,939,254.51 |
| Other Current Liabilities |
3,096,677.80 |
| Sub-Total of Current Liabilities |
502,011,116.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,958,530.53 |
| Other Non-Current Liabilities |
16,988,029.10 |
| Sub-Total of Non-Current Liabilities |
39,745,392.42 |
| Total Liabilities |
541,756,508.48 |
| Paid-In Capital(Or Share Stock) |
2,757,484,192.00 |
| Capital Surplus |
3,634,588,708.84 |
| Surplus Reserve |
150,323,143.76 |
| LESS:Treasury Stock |
33,943,125.48 |
| Undistributed Profits |
-1,596,969,147.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,606,615,056.69 |
| Owner's Equity（Stockholder's Equity） |
4,606,615,056.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,148,371,565.17 |
